We therefore propose a model in which gut-derived low-grade endotoxemia drives myeloid secretion of Galectin-3, which in turn sustains constitutive LAG3 expression on Treg cells and contributes to Treg cell insufficiency and islet autoimmunity. The gene discussed is LGALS3; the disease is serum lipopolysaccharide activity.